Cargando…

Correlation of lipoprotein-associated phospholipase A2 and cerebral microbleeds in patients with acute ischaemic stroke

BACKGROUND AND AIMS: Cerebral microbleeds (CMBs) increase the risk of stroke occurrence and recurrence,and affect the prognosis of stroke patients. Therefore, identifying biological markers that predict CMBs after stroke is urgently needed. This study explored whether high levels of lipoprotein-asso...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiaojiu, Liu, Lu, Jiang, Nan, Liu, Yufeng, Wang, Qing, Tang, Xiaohong, Zhai, Qijin, Zhao, Liandong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749267/
https://www.ncbi.nlm.nih.gov/pubmed/36517761
http://dx.doi.org/10.1186/s12883-022-03000-w
_version_ 1784850004582596608
author Zhang, Xiaojiu
Liu, Lu
Jiang, Nan
Liu, Yufeng
Wang, Qing
Tang, Xiaohong
Zhai, Qijin
Zhao, Liandong
author_facet Zhang, Xiaojiu
Liu, Lu
Jiang, Nan
Liu, Yufeng
Wang, Qing
Tang, Xiaohong
Zhai, Qijin
Zhao, Liandong
author_sort Zhang, Xiaojiu
collection PubMed
description BACKGROUND AND AIMS: Cerebral microbleeds (CMBs) increase the risk of stroke occurrence and recurrence,and affect the prognosis of stroke patients. Therefore, identifying biological markers that predict CMBs after stroke is urgently needed. This study explored whether high levels of lipoprotein-associated phospholipase A2(Lp-PLA2) are associated with an increased risk of CMBs in patients with acute ischaemic stroke (AIS). METHODS: From April 2020 to October 2021, we enrolled 242 patients with AIS. At admission, the plasma levels of Lp-PLA2 were measured in all patients as well as the number of CMBs and white matter lesions. According to the results of the Susceptibility Weighted Imaging (SWI), the patients were divided into a CMB group and a no-CMB group. The groups were compared with univariate and multivariate analyses to clarify the correlation between Lp-PLA2 levels and CMBs, and the optimal cut-off value of Lp-PLA2 that predicted CMBs was determined from the receiver-operating characteristic curve. RESULTS: CMBs were detected in 71 (29.3%) of the 242 AIS patients. The median Lp-PLA2 level was 182.79 ng/ml. Using the 1st quartile of Lp-PLA2 levels (the lowest levels) as the reference group, univariate logistic regression analysis showed that individuals in the 4th quartile (the highest levels) had a higher risk of CMBs (odds ratio [OR] = 1.460, 95% confidence interval [CI]: 1.188–1.795, P = 0.000). This correlation persisted after adjusting for relevant risk factors (OR = 1.370, 95% CI: 1.096–1.713, P = 0.006). The optimal cut-off value of Lp-PLA2 that predicted the occurrence of CMBs was 184.36 ng/ml; at this threshold, the sensitivity was 69.0%, and the specificity was 60.2%. CONCLUSIONS: Our data suggest that a high level of Lp-PLA2 in patients with AIS is a potential risk factor for CMBs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12883-022-03000-w.
format Online
Article
Text
id pubmed-9749267
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97492672022-12-15 Correlation of lipoprotein-associated phospholipase A2 and cerebral microbleeds in patients with acute ischaemic stroke Zhang, Xiaojiu Liu, Lu Jiang, Nan Liu, Yufeng Wang, Qing Tang, Xiaohong Zhai, Qijin Zhao, Liandong BMC Neurol Research Article BACKGROUND AND AIMS: Cerebral microbleeds (CMBs) increase the risk of stroke occurrence and recurrence,and affect the prognosis of stroke patients. Therefore, identifying biological markers that predict CMBs after stroke is urgently needed. This study explored whether high levels of lipoprotein-associated phospholipase A2(Lp-PLA2) are associated with an increased risk of CMBs in patients with acute ischaemic stroke (AIS). METHODS: From April 2020 to October 2021, we enrolled 242 patients with AIS. At admission, the plasma levels of Lp-PLA2 were measured in all patients as well as the number of CMBs and white matter lesions. According to the results of the Susceptibility Weighted Imaging (SWI), the patients were divided into a CMB group and a no-CMB group. The groups were compared with univariate and multivariate analyses to clarify the correlation between Lp-PLA2 levels and CMBs, and the optimal cut-off value of Lp-PLA2 that predicted CMBs was determined from the receiver-operating characteristic curve. RESULTS: CMBs were detected in 71 (29.3%) of the 242 AIS patients. The median Lp-PLA2 level was 182.79 ng/ml. Using the 1st quartile of Lp-PLA2 levels (the lowest levels) as the reference group, univariate logistic regression analysis showed that individuals in the 4th quartile (the highest levels) had a higher risk of CMBs (odds ratio [OR] = 1.460, 95% confidence interval [CI]: 1.188–1.795, P = 0.000). This correlation persisted after adjusting for relevant risk factors (OR = 1.370, 95% CI: 1.096–1.713, P = 0.006). The optimal cut-off value of Lp-PLA2 that predicted the occurrence of CMBs was 184.36 ng/ml; at this threshold, the sensitivity was 69.0%, and the specificity was 60.2%. CONCLUSIONS: Our data suggest that a high level of Lp-PLA2 in patients with AIS is a potential risk factor for CMBs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12883-022-03000-w. BioMed Central 2022-12-14 /pmc/articles/PMC9749267/ /pubmed/36517761 http://dx.doi.org/10.1186/s12883-022-03000-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Zhang, Xiaojiu
Liu, Lu
Jiang, Nan
Liu, Yufeng
Wang, Qing
Tang, Xiaohong
Zhai, Qijin
Zhao, Liandong
Correlation of lipoprotein-associated phospholipase A2 and cerebral microbleeds in patients with acute ischaemic stroke
title Correlation of lipoprotein-associated phospholipase A2 and cerebral microbleeds in patients with acute ischaemic stroke
title_full Correlation of lipoprotein-associated phospholipase A2 and cerebral microbleeds in patients with acute ischaemic stroke
title_fullStr Correlation of lipoprotein-associated phospholipase A2 and cerebral microbleeds in patients with acute ischaemic stroke
title_full_unstemmed Correlation of lipoprotein-associated phospholipase A2 and cerebral microbleeds in patients with acute ischaemic stroke
title_short Correlation of lipoprotein-associated phospholipase A2 and cerebral microbleeds in patients with acute ischaemic stroke
title_sort correlation of lipoprotein-associated phospholipase a2 and cerebral microbleeds in patients with acute ischaemic stroke
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749267/
https://www.ncbi.nlm.nih.gov/pubmed/36517761
http://dx.doi.org/10.1186/s12883-022-03000-w
work_keys_str_mv AT zhangxiaojiu correlationoflipoproteinassociatedphospholipasea2andcerebralmicrobleedsinpatientswithacuteischaemicstroke
AT liulu correlationoflipoproteinassociatedphospholipasea2andcerebralmicrobleedsinpatientswithacuteischaemicstroke
AT jiangnan correlationoflipoproteinassociatedphospholipasea2andcerebralmicrobleedsinpatientswithacuteischaemicstroke
AT liuyufeng correlationoflipoproteinassociatedphospholipasea2andcerebralmicrobleedsinpatientswithacuteischaemicstroke
AT wangqing correlationoflipoproteinassociatedphospholipasea2andcerebralmicrobleedsinpatientswithacuteischaemicstroke
AT tangxiaohong correlationoflipoproteinassociatedphospholipasea2andcerebralmicrobleedsinpatientswithacuteischaemicstroke
AT zhaiqijin correlationoflipoproteinassociatedphospholipasea2andcerebralmicrobleedsinpatientswithacuteischaemicstroke
AT zhaoliandong correlationoflipoproteinassociatedphospholipasea2andcerebralmicrobleedsinpatientswithacuteischaemicstroke